ClinicalTrials.gg
RecruitingNCT07200271Updated Oct 1, 2025

Surgical Management of Lateral Ankle Instability: Modified Broström-Gould Versus Arthroscopic Allograft Reconstruction of the Anterior Talofibular and Calcaneofibular Ligaments.

An interventional study of Arthroscopic reconstruction surgery and Open surgery in Ankle Sprain, sponsored by Universidad Francisco de Vitoria. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by Universidad Francisco de Vitoria · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Ankle Injuries with a site in Spain — 1 open to participants now, 1 under way, none of them phase 3. Ankle Injuries · Spain.

Planned enrollment
7th of 13
36 · median 36
Started
2025
the only one that year
No phase
12 of 15
1 open now
Registered
15th of 15
by date

Among the 15 studies in Ankle Injuries with a site in Spain, this one is the 7th largest by planned enrollment of the 13 interventional ones that give a count, is the only one that started in 2025, is one of 12 with no phase, and was the 15th registered.

Ankle Injuries

354 studies on the registry are indexed under Ankle Injuries; 77 are open to participants now.

Browse Ankle Injuries studies →

Open to participants now

1 of the 15 studies in Ankle Injuries with a site in Spain is open now.

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 47 Ankle Injuries studies recruiting now, 11 (23%) set no upper age limit and 33 (70%) stop at 75 or younger; 10 take children under 18; 8 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Ankle Injuries with a site in Spain, or all of them as a file.
02

Study summary

Primary Objective:

To clarify whether arthroscopic reconstruction with allograft provides tangible benefits over the modified open Broström-Gould technique, or if both are equivalent in efficacy and safety. The clinical AOFAS scale will be used for assessment.

Secondary Objectives:

To determine if there are differences in health outcomes and patient-perceived pain using the specific SP-36 scale and verbal numeric rating scale (VNRS). Additionally, to assess differences in postoperative complication rates and time to return to daily life activities between the two surgical techniques.

Study Design:

Prospective, randomized, controlled clinical trial with two parallel groups stratified by age and functional demand.

Condition or Disorder Being Studied:

Chronic lateral ankle instability.

Study Population and Sample Size:

The target population includes subjects diagnosed with chronic lateral ankle instability. The study population consists of patients diagnosed in the Orthopedics consultations at Hospital Infanta Elena who meet the inclusion and exclusion criteria. Based on sample size calculations, a total of 36 patients will be recruited. However, due to the prospective nature and stratification by epidemiological and functional variables, the sample size may be increased to ensure comparable groups in each stratum.

Study Timeline and Estimated Completion Date:

The study is expected to begin in the third quarter of 2025. Recruitment is estimated to last 24 months, with a follow-up period of 12 months, for a total duration of 3 years, ending in the third quarter of 2028.

03

Conditions studied

  • Ankle Sprain

Browse trials for

Keywords

  • ALLOGRAFT
  • INSTABILITY
  • ANKLE
  • LIGAMENT
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Mandatory criteria (all must be marked "yes" in a drop-down tab):

  • Age >18 years
  • Subjective sensation of instability
  • Pathological anterior drawer and varus tilt compared to the contralateral side
  • Magnetic resonance imaging showing lesion of the anterior talofibular ligament (ATFL)

Specific criteria (must meet at least one, but can meet several, multiple choice option):

  • >30
  • High athletic demand (regularly participates in pivoting sports)
  • Ligamentous hyperlaxity (Beighton score >8)
  • First sprain more than 2 years ago
  • More than 5 sprains per year
  • Subfibular ossicle >1 cm
  • MRI with ATFL showing high T2 signal
  • MRI showing disruption/absence of ATFL

Exclusion criteria

Exclusion Criteria:

  • History of previous ankle surgery
  • Tibiotalar osteoarthritis or presence of chondral lesions on magnetic resonance imaging
  • Active infections
  • for surgery
  • Pregnancy
  • Lactation
  • Known allergy to bovine collagen
  • connective tissue disease
  • Active oncological process
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Active comparator
    Open surgery arm

    Open surgery consists of the modified Broström-Gould technique, which allows for the reconstruction of damaged ligaments using the patient's own tissues through an incision on the lateral side of the fibula.

    Procedure: Open surgery

  • Active comparator
    Arthroscopic surgery

    Arthroscopic reconstruction with allograft is a surgery in which a tendon (generally from a tissue bank) is used to reconstruct the ligaments. This technique is performed through small incisions using arthroscopy

    Procedure: Arthroscopic reconstruction surgery

Interventions

  • ProcedureArthroscopic reconstruction surgery

    Arthroscopic reconstruction with allograft, in which a tendon (generally from a tissue bank) is used to reconstruct the ligaments. This technique is performed through small incisions using arthroscopy.

  • ProcedureOpen surgery

    Open surgery consists of the modified Broström-Gould technique, which allows for the reconstruction of damaged ligaments using the patient's own tissues through an incision on the lateral side of the fibula. This technique has shown satisfactory functional results.

06

What researchers measure

Primary outcomes

  1. Clarify whether arthroscopic reconstruction with allograft provides tangible benefits over the modified open Broström-Gould technique, or if both are equivalent in efficacy and safety.

    Clarify whether arthroscopic reconstruction with allograft provides tangible benefits over the modified open Broström-Gould technique, or if both are equivalent in efficacy and safety. For this purpose, the clinical AOFAS (American Orthopedics Foot and Ankle Score) score will be used. The minimum value for the AOFAS score is 0 and the maximum value is 100. Higher scores on the AOFAS scale indicate a better outcome, meaning less pain, better function, and improved alignment.

    Time frame: From surgery to the end of the follow up at 12 months after surgery

Secondary outcomes

  1. Determine whether there are differences in health outcomes

    Determine whether there are differences in health outcomes using the specific SP-36 (Short Form Health Survey) scale, is a 36-item questionnaire designed to measure health-related quality of life, it measures eight items: physical functioning, role limitations due to physical health, bodily pain, general health perceptions, vitality (energy/fatigue), social functioning, role limitations due to emotional problems and mental health. The score goes from 0 (worst health status) to 100 (best health status).

    Time frame: From surgery to the end of the follow up at 12 months after surgery

  2. Determine whether there are differences in patient-perceived pain

    Determine whether there are differences in patient-perceived pain by using verbal numerical rating scale (VNRS). This score is widely used tool for assessing pain intensity, it measures pain from 0 (no pain) to 10 (worst paing imaginable).

    Time frame: From surgery to the end of the follow up at 12 months after surgery

  3. Determine whether there are differences between both groups in the rate of postoperative complications.

    Determine whether there are differences between both groups in the rate of postoperative complications, defined as: Delay or absence of surgical wound healing, superficial infection, deep infection, recurrence or persistence of instability, sural nerve and superficial peroneal nerve neuropathy and complex regional pain syndrome. They are all qualitative variables. They will be expressed in the categories: yes or no.

    Time frame: From surgery to the end of the follow up at 12 months after surgery

  4. Determine whether there are differences in time to return to normal life between the two surgical techniques.

    Determine whether there are differences in the time to return to normal life between the two surgical techniques. To do this, we will compare both groups in terms of time expressed in days.

    Time frame: From surgery to the end of the follow up at 12 months after surgery

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for Sep 2027, 24 months after the start.

Of 141 non-industry interventional studies with no phase under Ankle Injuries, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 31. This study's planned 24 months is above that.

Counting every sponsor, half of 144 studies reached it within 9 months; a quarter within 4 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 16, 2025
First posted
Oct 1, 2025
StartActual
Sep 1, 2025
Primary completionEst.
Sep 1, 2027
CompletionEst.
Sep 1, 2028
Last update
Oct 1, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07200271
Lead sponsor
Universidad Francisco de Vitoria
Collaborators
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Responsible party
Juan Chans Veres (Attending Physician, Foot and Ankle Unit, Department of Orthopaedic Surgery, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) — Principal investigator
First posted
Oct 1, 2025
Start date
Sep 1, 2025
Primary completion
Sep 1, 2027 (estimated)
Completion
Sep 1, 2028 (estimated)
Last update
Oct 1, 2025

Study contacts

Juan Chans Veres, Md, PhD
Contact
juan.chans@quironsalud.es
+34 678133294
Laura Conde Ruiz, MD
Contact
laura.conde@quironsalud.es
+34 695155570
Juan Chans Veres, MD-PhD
principal investigator · Hospital Universitario Infanta Elena

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion